Tegoprazan for the Prevention of Nonsteroidal Anti-Inflammatory Drug-Induced Peptic Ulcers: Ready to Challenge Proton Pump Inhibitors?
Gut and Liver · 15.07.2026 · 20 (4) · 499-501
DOI: 10.5009/gnl260224 ↗Kurz gefasst
Editorial in der Zeitschrift Gut and Liver, erschienen am 15.07.2026. Verfasst von Je Seong Kim. Beteiligte Einrichtung: Department of Internal Medicine, Chonnam National University Medical School, Hwasun, Korea. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Internal Medicine, Chonnam National University Medical School, Hwasun, Korea.
ORCID-Profile: Je Seong Kim
Zitieren
APA
Kim, J. S. (2026). Tegoprazan for the Prevention of Nonsteroidal Anti-Inflammatory Drug-Induced Peptic Ulcers: Ready to Challenge Proton Pump Inhibitors?. Gut and Liver, 20(4), 499-501. https://doi.org/10.5009/gnl260224
Vancouver
Kim JS. Tegoprazan for the Prevention of Nonsteroidal Anti-Inflammatory Drug-Induced Peptic Ulcers: Ready to Challenge Proton Pump Inhibitors?. Gut and Liver. 2026;20(4):499-501. doi:10.5009/gnl260224
BibTeX
@article{Kim2026,
author = {Kim, Je Seong},
title = {Tegoprazan for the Prevention of Nonsteroidal Anti-Inflammatory Drug-Induced Peptic Ulcers: Ready to Challenge Proton Pump Inhibitors?},
journal = {Gut and Liver},
year = {2026},
volume = {20},
number = {4},
pages = {499--501},
doi = {10.5009/gnl260224}
}
EUVIMED